News
2hon MSN
Nvidia should post beat and strong guidance in Q3, says Wedbush's Matt Bryson on new price target
Matt Bryson, Wedbush, joins 'Closing Bell Overtime' to talk why he decided to raise Nvidia's price target and what he expects ...
Wedbush downgraded Maplebear Inc., the parent of Instacart (NASDAQ:CART), to Underperform from Neutral, saying Amazon’s push into same-day perishable grocery delivery has sharpened competition and ...
Hosted on MSN8h
Instacart Gets A Wedbush Downgrade On Rising Pressure from Amazon’s Same-Day Grocery Push, Retail Maintains Its Pessimistic Stance
Instacart (CART) stock received a rating change from Wedbush, with the firm downgrading it to ‘Underperform’ from ‘Neutral’, ...
A consensus of analysts expects Nvidia (NASDAQ:NVDA) to report about $1.01 in earnings per share on roughly $45.92 billi ...
1don MSN
Nvidia's results likely another 'positive catalyst' for investors as AI use cases rise: Wedbush
Nvidia's (NVDA) upcoming quarterly results on August 27 are likely to be another “positive catalyst” for investors, Wedbush ...
Most analysts believe Nvidia (NVDA) will surpass consensus estimates across the board when it releases its second quarter ...
2hon MSN
Why JinkoSolar Fell Today
President Trump threatened to not approve any more solar projects going forward in a post on Truth Social, leading to a big ...
Nvidia's AI momentum is gaining traction as demand, China sales, and data center investments drive growth. Analysts expect strong earnings and long-term growth, supporting its dominant role in global ...
Shares of Maplebear Inc (NASDAQ:CART), which does business as Instacart, are down 3.2% at $44.07, after a downgrade from Wedbush to "underperform" from "neutral," with a price-target cut to $42 from ...
The SOC Investment Group has urged NASDAQ to probe Tesla’s $29 billion equity award to Elon Musk, raising concerns over ...
Downtown's Wedbush Center has lost about 69% of its value in seven years, according to an August appraisal. The 21-story ...
Wedbush analyst Laura Chico maintained a Buy rating on Jade Biosciences today and set a price target of $18.00. The company’s shares opened today at $7.76. Take advantage of TipRanks Premium at 50% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results